---
figid: PMC6682711__ajcr0009-1329-f2
figtitle: Autophagy signaling in HCC
organisms:
- NA
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC6682711
filename: ajcr0009-1329-f2.jpg
figlink: /pmc/articles/PMC6682711/figure/fig02/
number: F2
caption: 'Autophagy signaling in HCC. A. PI3K/AKT/mTOR: Classic autophagy: Binding
  of growth factors to receptors triggers PI3K, and then activation of PI3K catalyzes
  the production of PIP3, phosphorylation of PIP3, and activation of Akt serine/threonine
  kinase. Subsequently, phosphorylation of AKT activates mTORC1, thereby inhibiting
  autophagy. In addition, activated AKT leads to activation of Rheb. Rheb then activates
  mTORC1. In addition to direct or indirect activation of mTORC1, active AKT can also
  directly regulate transcription leading to inhibition of autophagy. B. The RAS/RAF/MEK/ERK
  pathway: RAS switches from inactive (GDP-bound) to the active (GTP-bound) form.
  Activated RAS binds and recruits RAF kinase to the cell membrane for RAF dimerization
  and activation. Subsequently, activated RAF phosphorylates and activates MEK; MEK
  in turn phosphorylates and activates ERK/MAPK. Finally, phosphorylated ERK directly
  activates autophagy, or phosphorylates a variety of substrates that trigger autophagy
  by inhibiting mTORC1. C. The Wnt/β-catenin signaling pathway: This pathway can negatively
  regulate autophagy. β-catenin is a special target for degradation by autophagy in
  starvation stress. D. The AMPK signaling pathway: AMPK is an αβγ heterotrimer that
  is activated by decreasing ATP concentrations and increasing AMP concentrations.
  It induces autophagy via the activation of ULK1 or the inactivation of mTOR.'
papertitle: 'New insights into autophagy in hepatocellular carcinoma: mechanisms and
  therapeutic strategies.'
reftext: Shuo Yang, et al. Am J Cancer Res. 2019;9(7):1329-1353.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.907846
figid_alias: PMC6682711__F2
figtype: Figure
redirect_from: /figures/PMC6682711__F2
ndex: 28b90271-df12-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6682711__ajcr0009-1329-f2.html
  '@type': Dataset
  description: 'Autophagy signaling in HCC. A. PI3K/AKT/mTOR: Classic autophagy: Binding
    of growth factors to receptors triggers PI3K, and then activation of PI3K catalyzes
    the production of PIP3, phosphorylation of PIP3, and activation of Akt serine/threonine
    kinase. Subsequently, phosphorylation of AKT activates mTORC1, thereby inhibiting
    autophagy. In addition, activated AKT leads to activation of Rheb. Rheb then activates
    mTORC1. In addition to direct or indirect activation of mTORC1, active AKT can
    also directly regulate transcription leading to inhibition of autophagy. B. The
    RAS/RAF/MEK/ERK pathway: RAS switches from inactive (GDP-bound) to the active
    (GTP-bound) form. Activated RAS binds and recruits RAF kinase to the cell membrane
    for RAF dimerization and activation. Subsequently, activated RAF phosphorylates
    and activates MEK; MEK in turn phosphorylates and activates ERK/MAPK. Finally,
    phosphorylated ERK directly activates autophagy, or phosphorylates a variety of
    substrates that trigger autophagy by inhibiting mTORC1. C. The Wnt/β-catenin signaling
    pathway: This pathway can negatively regulate autophagy. β-catenin is a special
    target for degradation by autophagy in starvation stress. D. The AMPK signaling
    pathway: AMPK is an αβγ heterotrimer that is activated by decreasing ATP concentrations
    and increasing AMP concentrations. It induces autophagy via the activation of
    ULK1 or the inactivation of mTOR.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - DVL1
  - DVL1P1
  - DVL2
  - DVL3
  - IFT81
  - AXIN1
  - AXIN2
  - KRAS
  - HRAS
  - NRAS
  - KRT10
  - MTG1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - PTEN
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - AKT1
  - AKT2
  - AKT3
  - MAPK3
  - MAPK1
  - TSC2
  - TSC1
  - CCL26
  - CTNNB1
  - RHEB
  - RHEBP1
  - MTOR
  - RPTOR
  - APRT
  - MFAP1
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - ULK1
  - CSNK1A1
  - KRT1
  - CSNK1A1L
  - MAP2K1
  - MAP2K2
  - ATP8A2
  - Wnt5
  - Wnt4
  - wg
  - Wnt2
  - dsh
  - Axn
  - ras
  - Ras64B
  - Ras85D
  - aurA
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Pten
  - Raf
  - Akt
  - rl
  - gig
  - Tsc1
  - arm
  - Rheb
  - Crtc
  - Amph
  - SNF4Agamma
  - AMPKalpha
  - Atg1
  - CkIalpha
  - gish
  - ATPsynbeta
  - Atpalpha
  - AMP
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
